Table 4.
Means (and Standard Errors) of all variables at Pre-, Post-, and 3-month and 9-month Follow-up, and effect sizes, for full sample of participants who began treatment (n = 26)
| Pre | Post | 3-Month | 9-Month |
d |
|||
|---|---|---|---|---|---|---|---|
| Post | 3-month | 9-Month | |||||
| Primary Outcomes | |||||||
| GAD CSR | 5.69(0.13) | 3.10(0.21) | 3.22(0.21) | 2.98(0.30) | 2.97 | 2.83 | 2.34 |
| PSWQ | 67.15(1.39) | 53.23(2.07) | 50.68(1.96) | 49.00(2.39) | 1.58 | 1.94 | 1.86 |
| DASS-Anxiety | 12.23(1.57) | 4.32(0.91) | 3.24(0.74) | 4.10(0.81) | 1.23 | 1.47 | 1.30 |
| DASS-Stress | 24.54(1.88) | 10.03(1.35) | 11.92(1.24) | 11.17(1.42) | 1.77 | 1.58 | 1.61 |
| Secondary Outcomes | |||||||
| BDI | 17.81(1.57) | 5.99(1.10) | 6.68(1.24) | 7.69(1.70) | 1.74 | 1.57 | 1.24 |
| QOLI | .48(0.42) | 2.04(0.35) | 1.99(0.43) | 2.05(0.37) | 0.81 | 0.71 | 0.79 |
| # of add. dx. | 1.12(0.18) | 0.47(0.16) | 0.28(0.13) | 0.41(0.23) | 0.76 | 1.07 | 0.69 |
| Mechanism of Change | |||||||
| AAQ | 74.77(2.41) | 53.23(2.58) | 54.03(2.42) | 52.82(2.23) | 1.65 | 1.63 | 1.80 |
| MAAS | 50.04(2.65) | 57.55(2.59) | 60.39(2.30) | 59.75(2.60) | 0.57 | 0.83 | 0.74 |
Note. GAD= generalized anxiety disorder, CSR = Clinician’s Severity Rating from the Anxiety Disorders Interview Schedule for DSM-IV, Lifetime Version; PSWQ = Penn State Worry Questionnaire; DASS-Anxiety = Depression and Anxiety Stress Scales-Anxiety subscale; DASS-Stress = Depression and Anxiety Stress Scales- Stress subscale; BDI = Beck Depression Inventory; QOLI = Quality of Life Inventory; AAQ = Acceptance and Action Questionnaire; MAAS = Mindful Attention and Awareness Scale.